Skip to content

A Study of Tomato Products and Disease Risk

Tomato Products and Postprandial Oxidation and Inflammation: a Clinical Trial in Healthy Weight Men and Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00966550
Acronym
TOM
Enrollment
25
Registered
2009-08-27
Start date
2009-08-31
Completion date
2012-02-29
Last updated
2017-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammation

Keywords

Tomato, Nutrition

Brief summary

The purpose of this research study is to test whether certain compounds in tomatoes will help reduce factors in the subject's blood associated with disease risk. The investigators want to know if the tomato-associated compounds will lower or improve the status of these factors, like cholesterol and inflammation. In this research study, the subject will be asked to consume high fat test meals on two separate occasions. The investigators want to see how the subject's body responds to a standard high fat meal, one meal with tomato products and one meal without tomato products. The investigators will measure the subject's blood throughout the study period to determine if consumption of tomato products reduces factors in their blood associated with disease risk.

Detailed description

This study will take three weeks at most, and require one initial screening visit lasting approximately 45 minutes and two study visits each lasting approximately 6 - 8 hours. The investigators are looking for healthy, non-smoking male and female volunteers between the ages of 18 - 65, with no medical history of diabetics, heart, lung, kidney, stomach, or liver disease. The initial screening visit will determine subject' eligibility through height, weight and waist circumference measurements, blood glucose (finger prick) test and a fasting screening blood draw. There will be no compensation for the screening visit, other than transportation costs. If subject qualify, subject will continue to the two study visits. Each visit will require subject to have blood drawn several times during subject' study visit (total amount of blood equal to approximately 1 ½ tablespoons). To make this process more tolerable, a registered nurse will place a catheter (similar to what happens when you give blood) into subject's vein for ease in drawing blood. After the catheter placement and the first blood draw, subject will be asked to eat the test meal (tomato or non-tomato meal) and then subject will continue to have blood taken at specific time points for the next 6 hours. The investigators will also do an ultrasound on subject's arm to measure blood flow both before eating and midway through the 6 - hour study visit. The investigators will ask that subject not consume tomatoes or tomato products during the course of the study and record all food and beverages consumed on certain days.

Interventions

OTHERTomato

Tomato with high carb/fat meal

OTHERNon-tomato

Non-tomato with high carb/fat meal

Sponsors

Tomato Products Wellness Council
CollaboratorOTHER
Clinical Nutrition Research Center, Illinois Institute of Technology
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Male and female * Between ages of 18-65 * BMI between 19 and 24 and hsCRP \< 1mg/L * BMI between 25 and 35 and hsCRP \> 2.5mg/L * No clinical evidence of cardiovascular, respiratory, renal, GI or hepatic disease

Exclusion criteria

* Pregnant and/or lactating * allergies or intolerances to foods consumed in the study * fasting blood glucose \> 110mg/dL * taking OTC antioxidant supplements, prescription meds that may interfere with study endpoints * unusual dietary habits * actively trying to lose or gain weight * addicted to drugs or alcohol * medically documented psychiatric or neurological disturbances * smoker (past smoker allowed if cessation \> 2 years)

Design outcomes

Primary

MeasureTime frame
IL-6 Concentrations6 hour postprandial study

Countries

United States

Participant flow

Participants by arm

ArmCount
Tomato First Then Non-tomato
tomato High fat test meal Tomato products: tomato with High fat test meal
13
Non-tomato First Then Tomato
Non-tomato high fat test meal Non-tomato test meal: non-tomato with High fat test meal
12
Total25

Baseline characteristics

CharacteristicTomato First Then Non-tomatoNon-tomato First Then TomatoTotal
Age, Continuous24.9 years
STANDARD_DEVIATION 5
28.7 years
STANDARD_DEVIATION 10.7
27 years
STANDARD_DEVIATION 8
Sex: Female, Male
Female
8 Participants4 Participants12 Participants
Sex: Female, Male
Male
5 Participants8 Participants13 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 250 / 25
serious
Total, serious adverse events
0 / 250 / 25

Outcome results

Primary

IL-6 Concentrations

Time frame: 6 hour postprandial study

Population: Analysis was per-protocol (tomato vs Non-tomato) and no imputations were given for any missing values; missing values treated as a missing.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
TomatoIL-6 Concentrations2.2 pg/mLStandard Error 0.27
Non-tomatoIL-6 Concentrations2.6 pg/mLStandard Error 0.28
p-value: <0.0001Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Mar 27, 2026